 |
|
|
| |
EFFICACY AND SAFETY OF ELBASVIR/GRAZOPREVIR IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HCV GT 1, GT 4 AND GT 6 INFECTION (C-CORAL): A PHASE III RANDOMIZED MULTINATIONAL CLINICAL TRIAL
|
| |
| |
Reported by Jules Levin
APASL 2017 Feb 15-19 Shanghai, China
Lai Wei*, Eduard Burnevich; I-Shyan Sheen; Jeong Heo; Van Kinh Nguyen; Tawesak Tanwandee; Pin-Nan Cheng; Do Young Kim; Won Young Tak; Svetlana Kizhlo; Duan Zhongping; Cheng-Yuan Peng; Li Wen Liang; Barbara Evans; George Hanna; Eliav Barr; Michael Robertson; Paul Ingravallo, Rohit Talwani, Jacob George
*Peking University People's Hospital, Beijing, China
|
| |
|
|
|
|
|
